FDA — authorised 6 May 2010
- Status: approved
🇺🇸 Natazia in United States
FDA authorised Natazia on 6 May 2010
Marketing authorisations
FDA — authorised 6 May 2010
- Application: NDA022252
- Marketing authorisation holder: BAYER HLTHCARE
- Local brand name: NATAZIA
- Indication: TABLET — ORAL
- Status: approved
FDA
- Application: ANDA202349
- Marketing authorisation holder: WATSON LABS INC
- Local brand name: ESTRADIOL VALERATE AND DIENOGEST
- Indication: TABLET — ORAL
- Status: approved
Natazia in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is Natazia approved in United States?
Yes. FDA authorised it on 6 May 2010; FDA authorised it on 6 May 2010; FDA has authorised it.
Who is the marketing authorisation holder for Natazia in United States?
Mochida Pharmaceutical Co., Ltd. is the originator. The local marketing authorisation holder may differ — check the official source linked above.